Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
03/21/2013 | WO2013037812A1 Sulfonic acid salts of heterocyclylamide-substituted imidazoles |
03/21/2013 | WO2013037731A1 Novel polymorphic form of raltegravir potassium |
03/21/2013 | WO2013037566A1 Aqueous compositions comprising arbekacin |
03/21/2013 | WO2013037487A1 A particulate system for use in diminishing cell growth/inducing cell killing |
03/21/2013 | WO2013037068A1 Method for treatment of disorders of the gastrointestinal system |
03/21/2013 | WO2013036994A1 Compounds for the treatment of hcv |
03/21/2013 | WO2013024493A8 C-9 oxygen functionalized labdane derivates |
03/21/2013 | WO2013009826A9 Conjugating amines |
03/21/2013 | WO2013005042A3 Anti-viral therapy |
03/21/2013 | WO2012166859A3 Modulation of sphingosine 1-phosphate metabolizing enzymes for the treatment of negative-strand rna virus infections |
03/21/2013 | WO2012162578A3 Anti-viral compounds |
03/21/2013 | WO2012157984A3 Novel heteroaromatic compounds and use thereof |
03/21/2013 | WO2012154203A3 Filovirus fusion proteins and their uses |
03/21/2013 | WO2012153885A9 Rice-fermented food composition containing a rice-sweetened liquid, fermented by means of kimchi lactobacillus, as an effective ingredient, and having antibacterial and antiviral effects |
03/21/2013 | WO2011087995A3 Nitro - imidazo - oxazine derivatives and their use in the treatment of mycobacterial infections |
03/21/2013 | US20130072667 Use of rgm and its modulators |
03/21/2013 | US20130072531 Solid dispersion comprising an anti-hiv agent |
03/21/2013 | US20130072528 Methods for Treating HCV |
03/21/2013 | US20130072520 Antibacterial agents |
03/21/2013 | US20130072513 COMBINATIONS OF BERBERINE, ARTEMISININ, Loperamide AND THEIR DERIVATIVES TO TREAT MALARIA, DIARRHEA, TRAVELERS' DIARRHEA, DYSENTERY, DENGUE FEVER, PARASITES, CHOLERA AND VIRUSES |
03/21/2013 | US20130072512 Rifaximin ready-to-use suspension |
03/21/2013 | US20130072481 mTOR SELECTIVE KINASE INHIBITORS |
03/21/2013 | US20130072468 Substituted piperazines as cb1 antagonists |
03/21/2013 | US20130072465 Novel betulinic acid derivatives with antiviral activity |
03/21/2013 | US20130072423 Cd44v6 peptides as inhibitors of bacterial infections |
03/21/2013 | US20130072421 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
03/21/2013 | US20130071474 COMBINATIONS OF BERBERINE, ARTEMISININ, Loperamide AND THEIR DERIVATIVES TO TREAT MALARIA, DIARRHEA, TRAVELERS' DIARRHEA, DYSENTERY, DENGUE FEVER, PARASITES, CHOLERA AND VIRUSES |
03/21/2013 | US20130071466 Methods and compositions for treating gastric disorders |
03/21/2013 | US20130071439 Methods and compositions for treating biofilms |
03/21/2013 | US20130071435 Novel herbal formulation for the modulation of immune system of hiv infected patients and a process of preparation thereof |
03/21/2013 | US20130071432 Combination virotherapy for cancer |
03/21/2013 | US20130071429 Bunyavirus vaccine |
03/21/2013 | US20130071420 Yeast-based vaccines as immunotherapy |
03/21/2013 | US20130071419 Universal dengue virus sequences and methods of use |
03/21/2013 | US20130071416 Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae |
03/21/2013 | US20130071351 Combination therapy |
03/21/2013 | US20130071342 Cosmetic composition comprising coumestrol or a bean extract containing coumestrol for skin care |
03/21/2013 | US20130071320 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
03/21/2013 | DE69627384C5 Antiparasitäre zusammensetzung zur behandlung und zum schutz von haustieren Antiparasitic composition for the treatment and protection of house pets |
03/21/2013 | CA2855781A1 Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereof |
03/21/2013 | CA2852989A1 Compositions for treating bone diseases and broken bones |
03/21/2013 | CA2848806A1 Sulfonic acid salts of heterocyclylamide-substituted imidazoles |
03/21/2013 | CA2848762A1 Method for treatment of disorders of the gastrointestinal system |
03/21/2013 | CA2848615A1 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group |
03/21/2013 | CA2848611A1 Neutralising antibodies to the major exotoxins tcda and tcdb of clostridium difficile |
03/21/2013 | CA2848570A1 Compositions for the treatment of peripheral ulcers of various origins |
03/21/2013 | CA2848567A1 Products for healing of tissue wounds |
03/21/2013 | CA2848403A1 Hyr1-derived compositions and methods of treatment using same |
03/21/2013 | CA2847892A1 Compounds and pharmaceutical compositions for the treatment of viral infections |
03/21/2013 | CA2846107A1 Nitrogen containing compounds and their use |
03/21/2013 | CA2844923A1 Aqueous compositions comprising arbekacin |
03/21/2013 | CA2840242A1 Methods for treating hcv |
03/20/2013 | EP2570484A1 Influenza virus-like particles (VLPS) comprising hemagglutinin |
03/20/2013 | EP2570418A2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound |
03/20/2013 | EP2570413A1 Benzothiazinone derivatives as anti-tuberculosis agents |
03/20/2013 | EP2570411A1 Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity |
03/20/2013 | EP2570408A1 Hexaketide compound and medicinal use thereof |
03/20/2013 | EP2570130A1 Therapeutic agents containing bacteriophages against P. aeruginosa |
03/20/2013 | EP2570123A1 Use of 2,4-dichlorobenzyl alcohol having an anaesthetic effect |
03/20/2013 | EP2569436A2 Recombinant hcmv and rhcmv vectors and uses thereof |
03/20/2013 | EP2569326A2 Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling |
03/20/2013 | EP2569324A1 Aminoglycoside derivatives |
03/20/2013 | EP2569273A1 Novel antimicrobial compounds and uses thereof |
03/20/2013 | EP2569267A1 Improved methods for preparing squalene |
03/20/2013 | EP2569016A1 Pharmaceutical compositions comprising antisense oligonucleotides and methods of using same |
03/20/2013 | EP2569005A1 Furin and biologically active derivatives thereof for use in the prevention or treatment of an inflammatory disease |
03/20/2013 | CN1606554B Beta-lactamyl vasopressin v1a antagonists |
03/20/2013 | CN102985438A C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitors |
03/20/2013 | CN102985402A Tranylcypromine derivatives as inhibitors of histone demethylase LSD1 and/or LSD2 |
03/20/2013 | CN102985112A Pharmaceutical composition for treatment and prevention of herpesvirus infections |
03/20/2013 | CN102985109A Homodimeric protein constructs |
03/20/2013 | CN102985107A Immunogenic influenza composition |
03/20/2013 | CN102985104A Methods and systems using pharmacokinetic and pharmacodynamic profiles in interferon-alpha therapeutic regimens |
03/20/2013 | CN102985095A Immunostimulatory and vaccine compositions |
03/20/2013 | CN102978219A Vibrio cross-protective antigen, and preparation and application thereof |
03/20/2013 | CN102978213A Gene segment for coding swine beta interferon and application thereof |
03/20/2013 | CN102978168A gM-negative EHV-mutants without heterologous elements |
03/20/2013 | CN102978167A Method for preparing nephropathogenic avian infectious bronchitis viruses and live vaccines by using cell lines |
03/20/2013 | CN102978166A Method for preparing newcastle disease viruses and vaccines by using serial passage cells, and products thereof |
03/20/2013 | CN102978126A Novel lactic acid bacterial strain, composition containing same and use thereof |
03/20/2013 | CN102977219A Hypo- and hyper-acetylated meningococcal capsular saccharides |
03/20/2013 | CN102977218A Method for extracting polysaccharide from buckwheat brans |
03/20/2013 | CN102977214A Recombinant protein HF2 used for methicillin-resistant staphylococcus aureus (MRSA) vaccine, and preparation method and application thereof |
03/20/2013 | CN102977208A Preparation method, application and medicine composition and preparation of specific egg yolk immunoglobulin (IgY) and acinetobacter baumannii, as well as preparation and kit |
03/20/2013 | CN102977194A Duck tembusu virus (DTMUV) E protein gene and application thereof |
03/20/2013 | CN102977171A Five-membered heterocycle modified 4'-spiro nucleoside compounds and application in virus resistance |
03/20/2013 | CN102977146A Adenine derivative and inclusion compound thereof |
03/20/2013 | CN102977123A Cephalosporins compound and pharmaceutically acceptable salt thereof |
03/20/2013 | CN102977118A Novel antibiotic of Gram-positive bacteria and its preparation method and use |
03/20/2013 | CN102977101A Doripenem monohydrate, pharmaceutical compositions thereof, preparation method thereof and uses thereof |
03/20/2013 | CN102977082A Isocoumarin compound as well as preparation method and application thereof |
03/20/2013 | CN102976999A Acetic acid [2-(2,5-dioxo-2,5-dihydro-1-pyrryl) ethyl] ester compound and synthetic method thereof |
03/20/2013 | CN102973952A DNA (deoxyribonucleic acid) vaccine for expressing infectious bursal disease virus polyprotein gene VP243, as well as construction method and application thereof |
03/20/2013 | CN102973951A Koi herpesvirus ORF25 nucleic acid vaccine |
03/20/2013 | CN102973940A Pharmaceutical composition for inhibiting or killing helicobacter pylori and use thereof |
03/20/2013 | CN102973938A Avian infectious bronchitis antigen-antibody complex and preparation method thereof |
03/20/2013 | CN102973936A Application of chitosan in avian vaccine composition preparation |
03/20/2013 | CN102973935A Chicken subunit triple vaccine, as well as preparation and application thereof |
03/20/2013 | CN102973934A Preparation method for Newcastle disease and avian influenza bi-combined inactivated vaccine |
03/20/2013 | CN102973933A Bivalent vaccine for porcine reproductive and respiratory syndrome and classical swine fever prevention or treatment, and preparation method thereof |